VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Friday, January 2, 2026
Stock Comparison
Advantech Co., Ltd. vs AstraZeneca PLC
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
Advantech Co., Ltd.
2395 · Taiwan Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Advantech Co., Ltd.'s moat claims, evidence, and risks.
View 2395 analysisAstraZeneca PLC
AZN · London Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into AstraZeneca PLC's moat claims, evidence, and risks.
View AZN analysisComparison highlights
- Moat score gap: AstraZeneca PLC leads (71 / 100 vs 62 / 100 for Advantech Co., Ltd.).
- Segment focus: Advantech Co., Ltd. has 3 segments (49% in Industrial Computer and Industrial Control); AstraZeneca PLC has 6 segments (41% in Oncology).
- Primary market structure: Competitive vs Oligopoly. Pricing power: Moderate vs Strong.
- Moat breadth: Advantech Co., Ltd. has 5 moat types across 3 domains; AstraZeneca PLC has 4 across 3.
Primary market context
Advantech Co., Ltd.
Industrial Computer and Industrial Control
Industrial PCs and industrial control computing (industrial automation, edge industrial computing)
Global
Industrial enterprises, system integrators, and industrial OEMs
Industrial computing OEM + solution integrator
49%
AstraZeneca PLC
Oncology
Innovator oncology therapeutics (branded prescription medicines)
Global
Hospitals, oncology clinics, payers
Innovator biopharmaceutical company
41%
Side-by-side metrics
Moat coverage
Shared moat types
No overlap yet.
Advantech Co., Ltd. strengths
AstraZeneca PLC strengths
Segment mix
Advantech Co., Ltd. segments
Full profile >Industrial Computer and Industrial Control
Competitive
Embedded Boards and Chassis
Competitive
After-sales Service and Others
Competitive
AstraZeneca PLC segments
Full profile >Oncology
Oligopoly
Cardiovascular, Renal and Metabolism (CVRM)
Competitive
Respiratory & Immunology (R&I)
Oligopoly
Vaccines & Immune Therapies (V&I)
Oligopoly
Rare Disease
Oligopoly
Other Medicines
Competitive
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.